Repeated blood–brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurr | AcademicGPT, tlooto

A phase I/II clinical trial investigating the combination of a nine-emitter implantable ultrasound device and carboplatin in patients with recurrent glioblastoma found that drug delivery to the brain (2024), Nature Communications, Carpentier A. | AcademicGPT, tlooto for Academic and Research